Target type: biologicalprocess
Expression of a single heavy chain allele during pre-B cell differentiation. [GOC:add, GOC:jal, ISBN:0781735149]
Pre-B cell allelic exclusion is a critical process in B cell development that ensures each B cell expresses only one functional immunoglobulin (Ig) heavy chain allele. This process is essential for maintaining the integrity of the immune system and preventing autoimmunity.
The process begins with the rearrangement of Ig heavy chain genes in pro-B cells. During this process, the variable (V), diversity (D), and joining (J) gene segments of the Ig heavy chain locus are randomly recombined, resulting in a unique Ig heavy chain protein.
If this rearrangement is successful, the pro-B cell expresses the newly generated Ig heavy chain protein on its surface, along with surrogate light chains, forming the pre-B cell receptor (pre-BCR). The pre-BCR signals through a complex signaling pathway that leads to several critical events, including:
* **Allelic exclusion:** The pre-BCR signal blocks further rearrangement of the other Ig heavy chain allele. This ensures that only one functional Ig heavy chain allele is expressed in each B cell.
* **Pre-B cell proliferation:** The pre-BCR signal triggers a wave of proliferation, allowing the B cell to expand and generate a clonal population.
* **Light chain gene rearrangement:** The pre-BCR signal promotes the initiation of Ig light chain gene rearrangement.
After the light chain genes are successfully rearranged, the B cell expresses a complete Ig molecule on its surface, forming the mature B cell receptor (BCR). The BCR can now bind to specific antigens and initiate an immune response.
Pre-B cell allelic exclusion is a tightly regulated process involving several molecular mechanisms, including:
* **Chromatin modifications:** The pre-BCR signal induces changes in chromatin structure that prevent further rearrangements of the second Ig heavy chain allele.
* **Transcription factors:** Several transcription factors are involved in regulating Ig gene expression and ensuring allelic exclusion, including Pax5, E2A, and Ikaros.
* **Signaling pathways:** The pre-BCR signal activates several signaling pathways, including the PI3K/Akt, Ras/MAPK, and NF-κB pathways, which contribute to the regulation of allelic exclusion.
Failure of allelic exclusion can lead to the production of B cells that express multiple Ig heavy chains. This can result in autoimmunity, as these cells may produce antibodies that target self-antigens. Therefore, pre-B cell allelic exclusion is essential for maintaining immune homeostasis and preventing autoimmune diseases.'
"
Protein | Definition | Taxonomy |
---|---|---|
Serine-protein kinase ATM | A serine-protein kinase ATM that is encoded in the genome of human. [PRO:CNA] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
pd 173074 | aromatic amine; biaryl; dimethoxybenzene; pyridopyrimidine; tertiary amino compound; ureas | antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; fibroblast growth factor receptor antagonist | |
caffeine | purine alkaloid; trimethylxanthine | adenosine A2A receptor antagonist; adenosine receptor antagonist; adjuvant; central nervous system stimulant; diuretic; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; environmental contaminant; food additive; fungal metabolite; geroprotector; human blood serum metabolite; mouse metabolite; mutagen; plant metabolite; psychotropic drug; ryanodine receptor agonist; xenobiotic | |
2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source | chromones; morpholines; organochlorine compound | autophagy inhibitor; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; geroprotector |
schizandrin b | schizandrin B: a phytogenic antineoplastic agent with anti-inflammatory activity; isolated from Schisandra plant | ||
thiourea | thiourea : The simplest member of the thiourea class, consisting of urea with the oxygen atom substituted by sulfur. Thiourea: A photographic fixative used also in the manufacture of resins. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance may reasonably be anticipated to be a carcinogen (Merck Index, 9th ed). Many of its derivatives are ANTITHYROID AGENTS and/or FREE RADICAL SCAVENGERS. | one-carbon compound; thioureas; ureas | antioxidant; chromophore |
ku 55933 | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one: specific inhibitor of the ataxia-telangiectasia mutated kinase ATM; structure in first source | ||
cgk 733 | diarylmethane | ||
nu 7026 | 2-(morpholin-4-yl)benzo(h)chromen-4-one: a radiosensitizing agent that inhibits DNA-dependent protein kinase; structure in first source | organic heterotricyclic compound; organooxygen compound | |
nu 7441 | 8-dibenzothiophen-4-yl-2-morpholin-4-yl-chromen-4-one: structure in first source | dibenzothiophenes | |
ku-0060648 | dibenzothiophenes | ||
dactolisib | dactolisib : An imidazoquinoline that is 3-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-c]quinoline substituted at position 1 by a 4-(1-cyanoisopropyl)phenyl group and at position 8 by a quinolin-3-yl group. A dual PI3K/mTOR inhibitor used in cancer treatment. dactolisib: antineoplastic agent that inhibits both phosphatidylinositol 3-kinase and mTOR | imidazoquinoline; nitrile; quinolines; ring assembly; ureas | antineoplastic agent; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; mTOR inhibitor |
ku 60019 | |||
cp 466722 | quinazolines | ||
(3R)-4-[2-(1H-indol-4-yl)-6-(1-methylsulfonylcyclopropyl)-4-pyrimidinyl]-3-methylmorpholine | indoles | ||
ve 821 | 3-amino-6-(4-(methylsulfonyl)phenyl)-N-phenylpyrazine-2-carboxamide: an antineoplastic agent; structure in first source | aromatic amide | |
torin 2 | torin 2 : A member of the class of pyridoquinolines that is benzo[h][1,6]naphthyridin-2-one carrying additional 3-(trifluoromethyl)phenyl and 6-aminopyridin-3-yl substituents at positions 1 and 9 respectively. It is a potent inhibitor of mTOR and exhibits anti-cancer properties. | aminopyridine; organofluorine compound; primary amino compound; pyridoquinoline | antineoplastic agent; mTOR inhibitor |
byl719 | proline derivative | ||
cc-115 | 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino(2,3-b)pyrazin-2(1H)-one: an mTOR kinase inhibitor; structure in first source | ||
vx-970 | berzosertib: an ATR kinase inhibitor | sulfonamide | |
etp-46464 | ETP-46464: inhibits ATM and Rad3-related kinase; structure in first source |